| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_366a19489c5e7eec53d9d57c5ca5657b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-02 |
| filingDate |
1978-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1980-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18dbce2c6c2246bcb3e69f5c472ce9f4 |
| publicationDate |
1980-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4220660-A |
| titleOfInvention |
Process for the treatment of humans suffering from undesired urotoxic side effects caused by cytostatically active alkylating agents |
| abstract |
The invention is related to a process for the treatment of humans suffering from undesired urotoxic side effects caused by cytostatically active alkylating agents administered to them against malign tumors, comprising administering a pharmacologically acceptable salt of a mercapto alkane sulfonic acid having the general formula HS-alk-SO34 to the human treated with the cytostatically active alkylating agent, in an amount ranging from 20% of the weight of the alkylating agent to the highest tolerated dosage of the salt of the mercapto alkane sulfonic acid, simultaneously or separately in combination with the alkylating agent. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7025998-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6352979-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6077838-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006063742-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007059341-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007298081-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7053240-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7820196-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7824705-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6245815-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5019596-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7229637-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003018063-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6291441-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4716242-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008249185-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6197831-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5244920-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005137419-A1 |
| priorityDate |
1977-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |